BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2025.
World J Gastroenterol. Dec 21, 2025; 31(47): 113156
Published online Dec 21, 2025. doi: 10.3748/wjg.v31.i47.113156
Table 1 Baseline demographic and clinicopathological characteristics, n (%)
Characteristics
Modeling group (n = 358)
Validation group (n = 45)
χ2/Z value
P value
Sex
Male244 (68.2)29 (64.4)0.1970.657
Female114 (31.8)16 (35.6)
Age ≥ 65241 (67.3)26 (57.8)1.8600.173
Chemotherapy28 (7.8)6 (13.4)2.4000.200
Prior endoscopic intervention144 (40.2)17 (37.8)0.0550.815
Diabetes63 (17.6)7 (15.6)0.1760.675
Hypertension113 (31.6)17 (37.8)2.8310.150
Antibiotic prophylaxis165 (16.1)20 (44.4)3.7590.053
Plastic stent placement254 (70.9)32 (71.1)0.0010.977
Metal stent placement11 (3.1)2 (4.4)1.2080.272
ENBD179 (50.0)20 (44.4)1.0330.309
Number of stents
088 (24.6)10 (22.2)0.8560.836
Single167 (46.6)22 (48.9)
Multiple103 (28.8)13 (28.9)
EST105 (29.3)24 (53.3)0.4400.507
RFA14 (3.9)6 (13.3)0.1560.693
Bismuth-Corlett classification
I153 (42.7)23 (51.1)86.0040.289
II135 (37.7)14 (31.1)
IIIa21 (5.9)4 (8.9)
IIIb14 (3.9)1 (2.2)
IV35 (9.8)3 (6.7)
Transfusion history18 (5.0)5 (11.1)4.8030.058
Hypokalemia57 (15.9)9 (20.0)27.8020.351
BMI (kg/m2), median (IQR)20.12 (18.18-21.96)21.10 (18.18-22.72)-2.1670.301
Total procedure time (minute), median (IQR)40.00 (25.00-50.00)35.00 (23.00-45.00)1.2320.218
ANC (× 109/L), median (IQR)5.66 (4.30-7.80)5.10 (3.76-7.00)2.2130.207
NLR, median (IQR)6.14 (3.80-10.88)5.00 (3.25-8.71)2.5010.102
TBIL (μmol/L), median (IQR)205.40 (116.00-339.50)166.60 (62.80-283.00)2.5280.124
DBIL (μmol/L), median (IQR)155.40 (74.42-253.40)126.10 (47.00-217.20)2.5160.052
AST (U/L), median (IQR)106.38 (60.49-189.85)80.00 (52.20-124.21)2.7460.056


Write to the Help Desk